Concepedia

Author

Jordi Bruix

Universitat de BarcelonaORCID

Also Known As

Alsinet, Clara, D Sellami, Ignacio Garcia Juarez, Ignacio Juarez, Ignacio Juárez, J BRUIX, J Bruix, J. BRUIX, J. Bruix, J., Bruix

707

Publications

127.3K

Citations

128

H-Index

144

Concepts

All Affiliations

Universitat de BarcelonaConsorci Institut D'Investigacions Biomediques August Pi I SunyerHospital Clínic de BarcelonaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasIcahn School of Medicine at Mount Sinai
JB

About

Jordi Bruix is an author at Universitat de Barcelona specializing in medicine, hepatology, and hepatocellular carcinoma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

64

135

35.9K

2

Health Sciences

33

53

9.4K

3

Engineering

4

4

352

4

Public Health

1

1

170

5

Biostatistics

1

1

10

Jordi Bruix

×

232

Publications

88.2K

Citations

102

H-Index

YearCitations

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro,

New England Journal of Medicine

2008

12.8K

Management of Hepatocellular Carcinoma: An Update Δσ

Jordi Bruix, Morris Sherman

Hepatology

2011

8.1K

Management of Hepatocellular Carcinoma *

Jordi Bruix, Morris Sherman

Hepatology

2005

5.9K

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet,

Journal of Hepatology

2001

4.1K

Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

Josep M. Llovet, Concepció Brú, Jordi Bruix

Seminars in Liver Disease

1999

3.8K

Hepatocellular carcinoma

Josep M. Llovet, Andrew K. Burroughs, Jordi Bruix

The Lancet

2003

3.6K

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jordi Bruix, Shukui Qin, Philippe Merle,

The Lancet

2016

3.6K

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Josep M. Llovet, María Isabel Real, Xavier Montañá,

The Lancet

2002

3.5K

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli,

The Lancet Oncology

2008

2K

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

Josep M. Llovet, Josep Fuster, Jordi Bruix

Hepatology

1999

1.7K

Page 1